跳至主要内容
临床试验/2022-501694-39-01
2022-501694-39-01招募中2 期

A Prospective Study Comparing [18F]mFBG PET-CT to [123I]mIBG Scanning in Neuroblastoma

Princess Maxima Center For Pediatric Oncology1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2024年9月23日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
58
试验地点
1
主要终点
Detected skeletal lesions on [18F]mFBG PET-CT and [123I]mIBG scanning

研究概览

简要总结

To compare the diagnostic performance of [18F]mFBG PET-CT to conventional [123I]mIBG SPECT-CT for the detection of skeletal lesions in patients with neuroblastoma

入排标准

年龄范围
0 years 至 64 years(0-17 Years, 18-64 Years)
接受健康志愿者

入选标准

  • Patient with (a clinical suspicion of) neuroblastoma who is referred for conventional [123I]mIBG imaging
  • Written informed consent from patients and/or from parents or legal guardians, according to local law and regulations

排除标准

  • [18F]mFBG imaging cannot be scheduled within two weeks of [123I]mIBG imaging
  • Pregnancy of patient

结局指标

主要结局

Detected skeletal lesions on [18F]mFBG PET-CT and [123I]mIBG scanning

Detected skeletal lesions on [18F]mFBG PET-CT and [123I]mIBG scanning

次要结局

  • Detected soft tissue lesions on [18F]mFBG and [123I]mIBG scanning
  • Radiation absorbed doses (mSv) for organs and tumour of [18F]mFBG imaging
  • Mean difference in number of detected lesions and limits of agreement, Cohen’s kappa
  • SUVmean for normal organs, SUVmax for tumour lesions

研究者

发起方
Princess Maxima Center For Pediatric Oncology
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Prof. Dr. G.A.M. Tytgat

Scientific

Princess Maxima Center For Pediatric Oncology

研究点 (1)

Loading locations...

相似试验